End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19,000 KRW | -1.09% | -1.91% | -19.66% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 81,029 | 100.0 % | 83,240 | 100.0 % | +2.73% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
95.9
%
| 77,605 | 95.8 % | 79,794 | 95.9 % | +2.82% |
Overseas
4.1
%
| 3,424 | 4.2 % | 3,446 | 4.1 % | +0.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eun-Hee Park
CEO | Chief Executive Officer | 57 | - |
Yong-Ki Park
DFI | Director of Finance/CFO | 63 | - |
Seung-Hee Han
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Chan-Bok Lee
SAM | Sales & Marketing | 55 | - |
Byung-Jin Lee
SAM | Sales & Marketing | 65 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jin-Hyoung Kim
BRD | Director/Board Member | 47 | 30/22/30 |
Jae-Don Park
BRD | Director/Board Member | 88 | - |
Eun-Hee Park
CEO | Chief Executive Officer | 57 | - |
Yong-Ki Park
DFI | Director of Finance/CFO | 63 | - |
Won-Myung Park
BRD | Director/Board Member | 65 | - |
Beon-Gil Choi
BRD | Director/Board Member | 49 | 30/22/30 |
Chun-Soo Im
BRD | Director/Board Member | 59 | 30/22/30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,906,701 | 3,860,982 ( 35.40 %) | 0 | 35.40 % |
Company contact information
KOREA PHARMA Co., Ltd.
87 Jeyakgongdan 3-gil Hyangnam-eup
18622, Hwaseong-si
+
http://www.koreapharma.co.krSector
Sales per region
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.66% | 16Cr | |
+32.09% | 69TCr | |
+29.39% | 59TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- A032300 Stock
- Company KOREA PHARMA Co., Ltd.